Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dermira, Inc.
Age
9–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent or assent (for subjects under legal adult age)
Completed Week 12 visit of either DRM01B-ACN03 or DRM01B-ACN04 studies.
Willing to comply with the protocol. Subjects under legal adult age will be assessed by the investigator as to their ability to comply with the protocol
Willing to refrain from using any treatments on the face for acne vulgaris, other than the investigational product, including topical or systemic antibiotics.
You may not be if
Abnormal clinically significant findings on physical exam, vital signs or ECG at Week 12 visit of either the DRM01-ACN03 or DMR01-ACN04 studies that would make further treatment with Olumacostat Glasaretil Gel contraindicated, as determined by the Investigator
Any other condition which, in the judgment of the investigator, would put the subject at unacceptable risk for participation in the study
